BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 4151467)

  • 1. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G
    Ser Haematol; 1972; 5(5):66-86. PubMed ID: 4151467
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 3. An immunologic approach to the treatment of cancer.
    MacEwen EG
    Vet Clin North Am; 1977 Feb; 7(1):65-75. PubMed ID: 191975
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current achievements in clinical oncoimmunology].
    Gorodilova VV
    Sov Med; 1977 Oct; (10):110-5. PubMed ID: 337523
    [No Abstract]   [Full Text] [Related]  

  • 5. An insight into cancer immunology and immunotherapy.
    Thompson RB
    Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
    [No Abstract]   [Full Text] [Related]  

  • 6. Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.
    Fefer A
    Isr J Med Sci; 1973 Mar; 9(3):350-65. PubMed ID: 4145461
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
    Bainbridge DR; Bendinelli M
    J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
    [No Abstract]   [Full Text] [Related]  

  • 8. Virus tumorigenesis and immunity: influence of immunostimulation and immunodepression.
    Friedman H; Ceglowski WS
    Johns Hopkins Med J Suppl; 1974; 3():187-209. PubMed ID: 4609083
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective elimination of marrow precursors with the bone-seeking isotope 89Sr: implications for hemopoiesis, lymphopoiesis, viral leukemogenesis and infection.
    Bennett M; Baker EE; Eastcott JW; Kumar V; Yonkosky D
    J Reticuloendothel Soc; 1976 Jul; 20(1):71-87. PubMed ID: 781225
    [No Abstract]   [Full Text] [Related]  

  • 10. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes.
    Isaak DD; Price JA; Reinisch CL; Cerny J
    J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to Friend leukemia virus in mice: effect of immunosuppression.
    Stutman O; Dupuy JM
    J Natl Cancer Inst; 1972 Nov; 49(5):1283-93. PubMed ID: 4405498
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity in leukemia.
    Gatti RA
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
    Mathé G; Thompson RB
    Dis Colon Rectum; 1973; 16(5):341-57. PubMed ID: 4590448
    [No Abstract]   [Full Text] [Related]  

  • 15. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.
    Berenson JR; Einstein AB; Fefer A
    J Immunol; 1975 Jul; 115(1):234-8. PubMed ID: 1080165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological studies of runting syndrome in rats inoculated with Friend virus.
    Takeichi N; Kuzumaki N; Kobayashi H
    Cancer Res; 1973 Dec; 33(12):3096-102. PubMed ID: 4148554
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunocompetent cell functions in mice infected with Friend leukemia virus.
    Bennett M; Steeves RA
    J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy of cancer. Basic principles, possibilities, dangers, problems and conditions].
    Meiss L; Romieu C; Serrou B
    Dtsch Med Wochenschr; 1973 Jun; 98(23):1179-85. PubMed ID: 4576228
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of runting syndrome and prevention of primary lymphomas in friend virus-tolerant rats.
    Takeichi N; Kuzumaki N; Kobayashi H
    Cancer Res; 1975 Mar; 35(3):729-33. PubMed ID: 1090364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.